ECRI, a global nonprofit specializing in healthcare and patient safety, has recently published a series of comprehensive assessments that delve into the heated issue of single-use medical devices against reprocessed counterparts in hospitals. The aim of these assessments is to help hospitals weigh the pros and cons in order to make informed decisions.
The challenge of choosing between disposable and reprocessed medical devices forms a significant aspect of hospital settings, particularly in the domain of Preventing Hospital Acquired Infections (HAIs). While one side of the argument touts single-use devices as an effective measure to minimise HAIs, critics highlight the staggering cost and undeniable environmental impact associated with the disposable culture.
The downloadable reports, conducted by ECRI-Penn Evidence-based Practice Center, not only review over 2,000 studies focussed on infection-prevention devices like hospital gowns and bedside devices such as laryngoscopes, but also other surgical items and scopes. Each assessment report comprises an indicative chart supporting single use, reuse, or an inconclusive stance, evaluated across clinical, economic, and environmental categories.
The key finding emphasized throughout the reports is that the decision-making process should not rely solely on the type of device, but a myriad of local factors. These include infection rates, supplier agreements, frequency of reuse, and most importantly, the methods of reprocessing.
ECRI acknowledges that while the preference leans towards single-use devices in infection prevention, the evidence supporting this claim fluctuates with the type of device in question. The research thus underscores the intricate balancing act between clinical outcomes, economic burdens, and environmental damage when selecting between disposable and reusable devices.
However, the existing evidence base leaves room for question, with several gaps identified. Studies into clinical outcomes and economic costs were notably less common than those scrutinizing the environmental impact. Amid this lack of concrete direction from clinical or economic evidence, the environmental influence may emerge as the deciding factor. Consequently, this study underlines the urgency for further focused research and enhanced transparency among manufacturers, healthcare institutions, and reprocessing companies.